Shopping Cart
Remove All
Your shopping cart is currently empty
BI-2545 is a potent and selective autotaxin (ATX) inhibitor with IC50 values of 2.2 nM and 3.4 nM for human and rat ATX, respectively, and reduces plasma LPA levels in rats.


| Description | BI-2545 is a potent and selective autotaxin (ATX) inhibitor with IC50 values of 2.2 nM and 3.4 nM for human and rat ATX, respectively, and reduces plasma LPA levels in rats. |
| Targets&IC50 | ATX (rat):3.4 nM, ATX (human):2.2 nM |
| In vitro | BI-2545, which exhibits single-digit nanomolar activity in enzyme assays (IC50 = 0.9 nM), demonstrates high potency in rat whole blood (IC50 = 4 nM) and possesses a clean hERG profile along with favorable pharmacokinetic properties [1]. |
| In vivo | In the rat PK/PD model, BI-2545 (10 mg/kg, p.o.) demonstrated a significant reduction in LPA levels, decreasing total plasma LPA by up to 90% [1]. |
| Synonyms | BI2545, BI 2545 |
| Molecular Weight | 527.42 |
| Formula | C23H19F6N5O3 |
| Cas No. | 2162961-71-7 |
| Smiles | C(NC(=O)C=1C=C2C(=CC1)N=NN2)[C@@H]3[C@@]4([C@]3(CN(C(OCC5=CC(C(F)(F)F)=CC(C(F)(F)F)=C5)=O)C4)[H])[H] |
| Relative Density. | 1.513 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 200 mg/mL (379.2 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.